APA (7th ed.) Citation

He Magee, M., Shaddinger, B., Collins, D., Siddiqi, S., & Soffer, J. (2015). The pharmacokinetics and safety of darapladib in subjects with severe renal impairment. British journal of clinical pharmacology, 80(4), 654-661. https://doi.org/10.1111/bcp.12661

Chicago Style (17th ed.) Citation

He Magee, Mindy, Bonnie Shaddinger, David Collins, Shabana Siddiqi, and Joseph Soffer. "The Pharmacokinetics and Safety of Darapladib in Subjects with Severe Renal Impairment." British Journal of Clinical Pharmacology 80, no. 4 (2015): 654-661. https://doi.org/10.1111/bcp.12661.

MLA (9th ed.) Citation

He Magee, Mindy, et al. "The Pharmacokinetics and Safety of Darapladib in Subjects with Severe Renal Impairment." British Journal of Clinical Pharmacology, vol. 80, no. 4, 2015, pp. 654-661, https://doi.org/10.1111/bcp.12661.